Improved Outcomes Using Tacrolimus/Sirolimus for Graft-versus-Host Disease Prophylaxis with a Reduced-Intensity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplant as treatment of Myelofibrosis期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Improved Outcomes Using Tacrolimus/Sirolimus for Graft-versus-Host Disease Prophylaxis with a Reduced-Intensity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplant as treatment of Myelofibrosis

Affiliation:	City of Hope Cancer Center, Departments of Hematology/HCT, Biostatistics, and Radiation Oncology, Duarte, California, and Kaiser BMT, Los Angeles, California

Abstract:

Keywords:
本文献已被 ScienceDirect 等数据库收录！